EMA Defers U.S. GMP Inspections Pending November Activation of Mutual Agreement

Drug Industry Daily
The European Medicines Agency is putting off plans for GMP inspections in the U.S. when possible, an EMA spokesperson confirmed this week, in anticipation of the November launch of a mutual agreement between the EU and U.S.

To View This Article:


Subscribe To Drug Industry Daily